Whereas the mechanism identified in this manuscript identifies aspects of the biology of MUC1 in modulating transcriptional effects, our in vivo and in vitro studies suggest FRA-1 can independently contribute to effects on tumor progression. The gene discussed is MUC1; the disease is neoplasm.